Skip to content

Pheochromocytoma Paraganglioma Syndrome 1 C3494181

Published: July 22, 2026Updated: August 25, 2026

A hereditary syndrome predisposing to tumors of the adrenal glands and paraganglia. Requires lifelong monitoring. Treatment involves surgery and sometimes targeted therapies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(endocrine)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Endocrine management

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Tumor Resection Surgery

Surgical removal of pheochromocytoma or paraganglioma tumors, which is the primary curative approach. Requires careful preoperative preparation and experienced surgical teams familiar with these tumor types.

surgical
3

Alpha-Adrenoceptor Blockade

Medical management using alpha-blockers to control blood pressure and prevent catecholamine surge complications before and after tumor manipulation. Typically initiated 10-14 days before any surgical procedure.

medication

Additional treatment options

Comprehensive Surveillance Protocol

Systematic screening for multiple tumors including periodic biochemical testing (plasma free metanephrines), imaging studies, and genetic re-evaluation. Since this is a hereditary syndrome, multiple tumors may develop over time.

monitoring

Beta-Adrenergic Blockade

Adjunctive medication to control tachycardia and arrhythmias after adequate alpha-blockade is established. Helps manage symptoms of catecholamine excess including palpitations and sweating.

medication

Genetic Counseling and Family Testing

Specialized counseling services to discuss hereditary implications, available genetic testing, reproductive options, and psychological support for patients and families affected by SDHD mutations.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Pheochromocytoma Paraganglioma Syndrome 1 C3494181?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Lenders JWM, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014.

guideline2014
2

Favier J, Amar L, Gimenez-Roqueplo AP. Paraganglioma and pheochromocytoma: from genetics to personalized medicine. Nat Rev Endocrinol. 2015.

review2015
3

Burnichon N, Briere JJ, Libe R, et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet. 2010.

clinical_trial2010
4

Jochmanova I, Pacak K. Predictive factors for complications and long-term outcome in patients with pheochromocytoma/paraganglioma. Front Endocrinol. 2016.

review2016

Medication Comparisons

Compare medications used to treat Pheochromocytoma Paraganglioma Syndrome 1 C3494181. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy